Results 111 to 120 of about 3,777,037 (252)

Triglyceride-glucose index and its combination with anthropometric obesity indicators are significant predictors of visceral obesity among the Newfoundland population

Scientific Reports
Visceral obesity (VO) is a critical risk factor for metabolic disorders and cardiovascular diseases. Although DXA, CT, or MRI are reliable tools for measuring visceral adiposity, their routine use is limited by cost and accessibility.
Shanshan Yu, Hongwei Zhang, Jianling Du, Guang Sun   +3 more
doaj   +1 more source

Sex-specific differences in the associations between adiposity indices and incident hyperuricemia among middle-aged and older adults: a nationwide longitudinal study

Frontiers in Endocrinology
ObjectiveAlthough obesity is a known risk for hyperuricemia (HUA), the associations between adiposity indices and incident HUA and whether sex-specific differences exist is still unknown. We aimed to investigate the associations between adiposity indices
Zhiyi Liu, Qinwu Zhou, Yuqiong Tang, Jiyong Li, Qiutong Chen, Hongguang Yang, Shuhan Zhou, Shuhan Zhou   +7 more
doaj   +1 more source

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aim Metabolic liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis, is a major cause of chronic liver dysfunction worldwide, creating an urgent need for effective treatments. This systematic literature review (SLR) and network meta‐analysis (NMA) systematically reviews and compares the efficacy and safety ...
Andrej Belančić, Christina Antza, Anastasios Poutachidis, Smaro Palaska, Elvira Meni Maria Gkrinia, Andrea Katrin Faour, Yusuf Ziya Sener, Seher Sener, Rehena Sultana   +8 more
wiley   +1 more source

Role of Visceral Adiposity Index as an Indicator of Metabolic Risk in Hypothyroidism - Review article

Visceral adiposity, or intra-abdominal fat accumulation, is now recognized as a metabolically active tissue that contributes significantly to insulin resistance, dyslipidemia, and cardiovascular morbidity.
Savitri Sheelin, Rajendra Kumar Soni, Amrish Chanana   +2 more
core   +1 more source

New therapeutic options for metabolic‐associated steatotic liver disease

British Journal of Clinical Pharmacology, EarlyView.
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley   +1 more source

Comparative performance of traditional and novel adiposity indices for predicting insulin resistance and metabolic syndrome in Chinese women with polycystic ovary syndrome

Frontiers in Nutrition
ObjectiveThis study aimed to comprehensively evaluate and compare the predictive performance of seven adiposity indices—both traditional (waist-to-hip ratio, WHR; waist-to-height ratio, WHtR) and novel (visceral adiposity index, VAI; Chinese visceral ...
Huichao Qin, Huichao Qin, Baichao Shi, Yabing Li, Fengjuan Lu, Muxin Guan, Jiannan Yu, Zhuwei Gao, Mengyi Zhu, Yang Liu, Hang Ge, Xiaoke Wu, Xiaoke Wu, Yuehui Zhang   +13 more
doaj   +1 more source

Longitudinal Association Between Visceral Adiposity Index and Arthritis-Diabetes Comorbidity Risk

Visceral adiposity (metabolic dysregulation) plays a role in chronic inflammation and contributes to many chronic diseases. However, it is unclear whether Visceral Adiposity Index (VAI) can be used to predict arthritis-diabetes risk.
zhang, Huidong
core   +1 more source

Hypertension in obesity: A focus on individualized pharmacotherapy and the role of body composition, on behalf of the European Society of Hypertension Working Group on Diabetes and Metabolic Risk Factors and Working Group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence

British Journal of Clinical Pharmacology, EarlyView.
Hypertension in obesity represents a major global health challenge, closely linked to the global epidemics of obesity, type 2 diabetes and metabolic dysfunction. Excess adiposity contributes to elevated blood pressure through multiple, interrelated mechanisms, including activation of the renin–angiotensin–aldosterone system, sympathetic nervous system ...
Christina Antza, Andrej Belancic, Jens Jordan, Alberto Esteban, Anna Oliveras, Ryan McNally, Panagiota Anyfanti, Jorie Versmissen, María S. Fernández‐Alfonso, Vasilios Kotsis, Thomas Weber, Alexandre Persu, Reinhold Kreutz   +12 more
wiley   +1 more source

Anthropometric markers of adiposity and visceral adiposity index (VAI) in patients with OSA

, 2013
Visceral adiposity is frequent in patients with obstructive sleep apnea (OSA), and OSA is associated with the Metabolic Syndrome (MetS) in both genders. The Visceral Adiposity Index (VAI) has been recently proposed as a marker of cardiometabolic risk in ...
Barbé F, Castrogiovanni A, Esquinas C, Marrone O, Buttacavoli M, Bonsignore M, Mazzuca E, Marotta AM, Barcelò A   +8 more
core  

Photogrammetric Reconstruction of 3D Human Anatomical Structures and Augmented Reality via Smartphone Technology

Clinical Anatomy, EarlyView.
ABSTRACT Limited access to cadavers necessitates the availability of digital resources for anatomy education. Smartphone‐based photogrammetry offers a promising solution for creating three‐dimensional (3D) and augmented reality (AR) models. This study compared two mobile photogrammetry applications (Qlone and Polycam) that have been used in modern ...
Sarita Phukwantong, Paphawarin Ma‐imjai, Benrita Jitaree, Athinan Prommahom   +3 more
wiley   +1 more source